Literature DB >> 2821703

Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.

N Mueller1.   

Abstract

The hypothesis that an infection plays a role in the etiology of Hodgkin's disease (HD) is suggested by both its clinical and histologic features. Its bimodal age-incidence pattern also suggests an infectious process among younger persons. In economically advantaged populations, the first peak occurs among young adults, while in disadvantaged populations, it occurs among children at a much lower frequency. It appears that the age distribution of HD shadows that of susceptibility to common childhood infections, such as the Epstein-Barr virus (EBV); furthermore, that risk of HD is increased among those susceptible to a relatively late infection, in parallel with infectious mononucleosis (IM), and it has been found that people who have had IM have about three times the expected rate of HD. Serologically, there is a consistent association between EBV and HD. As a group, patients have an altered antibody pattern against EBV which suggests chronic reactivation, both following and preceding diagnosis. This altered pattern is common to all age groups. Severity of infection may alter host control among younger people, while diminished cellular immunity with aging may allow similar reactivation among older persons. Whether the EBV plays a direct role or simply reflects the action of a more primary factor is unknown.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821703      PMCID: PMC2590239     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  47 in total

1.  Epidemiological evidence of the nature of Hodgkin's disease.

Authors:  B MACMAHON
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

2.  Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

Authors:  C H Ten Napel; T H The; J Van Egten-Bijker; G C de Gast; M R Halie; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

3.  Hodgkin's disease in the elderly.

Authors:  F P Li; J Lokich; M Costanza; W C Moloney; S Hellman
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

4.  Hodgkin's disease in Connecticut: histology and age distribution.

Authors:  G T O'Conor; P Correa; B Christine; L Axtell; M Myers
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

5.  A cohort study of cancer following infectious mononucleosis.

Authors:  R R Connelly; B W Christine
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

6.  Infectious mononucleosis and the empirical risk of cancer.

Authors:  R W Miller; G W Beebe
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

7.  Hodgkin's Disease, tonsillectomy and family size.

Authors:  N Gutensohn; F P Li; R E Johnson; P Cole
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

8.  Hodgkin's disease: one entity or two?

Authors:  D W Smithers
Journal:  Lancet       Date:  1970-12-19       Impact factor: 79.321

9.  Hodgkin's disease in the elderly.

Authors:  J J Lokich; G S Pinkus; W C Moloney
Journal:  Oncology       Date:  1974       Impact factor: 2.935

10.  Infectious mononucleosis and Hodgkin's disease.

Authors:  N Muñoz; R J Davidson; B Witthoff; J E Ericsson; G De-Thé
Journal:  Int J Cancer       Date:  1978-07-15       Impact factor: 7.396

View more
  7 in total

1.  Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.

Authors:  D Kube; M Vockerodt; O Weber; K Hell; J Wolf; B Haier; F A Grässer; N Müller-Lantzsch; E Kieff; V Diehl; H Tesch
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

2.  Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus.

Authors:  Eric J Yager; In-Jeong Kim; Michael L Freeman; Kathleen G Lanzer; Claire E Burkum; Tres Cookenham; David L Woodland; Marcia A Blackman
Journal:  Immun Ageing       Date:  2010-02-02       Impact factor: 6.400

3.  Association of Hodgkin's lymphoma with Epstein Barr virus infection.

Authors:  Elmir Cickusić; Jasminka Mustedanagić-Mujanović; Ermina Iljazović; Zinaida Karasalihović; Ina Skaljić
Journal:  Bosn J Basic Med Sci       Date:  2007-02       Impact factor: 3.363

4.  CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.

Authors:  R M Leskowitz; X Y Zhou; F Villinger; M H Fogg; A Kaur; P M Lieberman; F Wang; H C Ertl
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

5.  New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.

Authors:  D J Reynolds; P M Banks; M L Gulley
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

6.  Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells.

Authors:  G Khan; P J Coates; R K Gupta; H O Kangro; G Slavin
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  A specialist leukaemia/lymphoma registry in the UK. Part 2: Clustering of Hodgkin's disease.

Authors:  F E Alexander; J Williams; P A McKinney; T J Ricketts; R A Cartwright
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.